| Authors: |
Alsuliman T; The Faculty of Medicine, Sorbonne University, Paris 75012, France; Department of Hematology and Cellular Therapy, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM, Unité Mixte de Recherche 938, Paris, France. Electronic address: dr.tameem.soliman@gmail.com., Rojas RMM; The Faculty of Medicine, Sorbonne University, Paris 75012, France; Department of Hematology and Cellular Therapy, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM, Unité Mixte de Recherche 938, Paris, France., Basha AA; Hematology and Oncology Department, Saudi German Hospital, Dubai, United Arab Emirates., Musiu P; The Faculty of Medicine, Sorbonne University, Paris 75012, France; Department of Hematology and Cellular Therapy, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM, Unité Mixte de Recherche 938, Paris, France., Magro L; Maladies du Sang, Hôpital Huriez, Centre Hospitalier Universitaire de Lille, Lille, France., Testi AM; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Mohty M; The Faculty of Medicine, Sorbonne University, Paris 75012, France; Department of Hematology and Cellular Therapy, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM, Unité Mixte de Recherche 938, Paris, France. |
